Clinical trial
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer…
NCT00201539 · Norwegian University of Science and Technology, Other · Completed
Key facts
| NCT number | NCT00201539 |
|---|---|
| Title | Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients |
| Official title | Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients: A Randomized, Double-blind Cross-over Comparison of a Double Bedtime Dose Ver-sus Two Standard Doses at Bedtime and at Night |
| Lead sponsor | Norwegian University of Science and Technology, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | single dose Morphine, double dose Morphine, placebo |
| Enrollment | 19 |
| Start date | Apr 1, 2002 |
| Primary completion | Nov 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 8, 2015 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: